Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2010 1
2012 1
2015 2
2016 2
2017 3
2018 6
2019 2
2020 1
2021 2
2022 6
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Telangiectasia, hereditary hemorrhagic, type 1"
Page 1
Treatments of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Network Meta-Analysis.
Chitsuthipakorn W, Hoang MP, Kanjanawasee D, Seresirikachorn K, Snidvongs K. Chitsuthipakorn W, et al. Curr Allergy Asthma Rep. 2023 Dec;23(12):689-701. doi: 10.1007/s11882-023-01116-8. Epub 2023 Nov 23. Curr Allergy Asthma Rep. 2023. PMID: 37995018 Review.
PURPOSE OF REVIEW: To analyze and compare the effects of epistaxis treatments for Hereditary Hemorrhagic Telangiectasia (HHT) patients. RECENT FINDINGS: Of total of 21 randomized controlled trials (RCT), the data from 15 RCTs (697 patients, 7 treatments: timo …
PURPOSE OF REVIEW: To analyze and compare the effects of epistaxis treatments for Hereditary Hemorrhagic Telangiectasia …
Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Thiele B, Abdel-Aty Y, Marks L, Lal D, Marino M. Thiele B, et al. Ann Otol Rhinol Laryngol. 2023 Jan;132(1):82-90. doi: 10.1177/00034894221078075. Epub 2022 Feb 12. Ann Otol Rhinol Laryngol. 2023. PMID: 35152768 Review.
OBJECTIVES: Hereditary hemorrhagic telangiectasia (HHT) is a common inherited condition characterized by mucosal telangiectasias, recurrent epistaxis, and arteriovenous malformations. ...
OBJECTIVES: Hereditary hemorrhagic telangiectasia (HHT) is a common inherited condition characterized by mucosal telang …
Liver transplantation for hereditary hemorrhagic telangiectasia: a systematic review.
Felli E, Addeo P, Faitot F, Nappo G, Oncioiu C, Bachellier P. Felli E, et al. HPB (Oxford). 2017 Jul;19(7):567-572. doi: 10.1016/j.hpb.2017.03.005. Epub 2017 Apr 17. HPB (Oxford). 2017. PMID: 28427830 Free article. Review.
AIM: To evaluate the indications, timing and results of liver transplantation in patients affected by hereditary hemorrhagic telangiectasia (HHT), by undertaking a systematic review of the current literature. ...Thirty-eight articles have been excluded becaus …
AIM: To evaluate the indications, timing and results of liver transplantation in patients affected by hereditary hemorrhagic …
Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia: An Evidence-based Review.
Halderman AA, Ryan MW, Marple BF, Sindwani R, Reh DD, Poetker DM. Halderman AA, et al. Am J Rhinol Allergy. 2018 Jul;32(4):258-268. doi: 10.1177/1945892418768588. Epub 2018 May 10. Am J Rhinol Allergy. 2018. PMID: 29745243 Review.
Objective Epistaxis is a primary complaint in 90% to 96% of patients with hereditary hemorrhagic telangiectasia (HHT). Numerous surgical and medical treatments aim to decrease the frequency and severity of epistaxis in this patient population. ...
Objective Epistaxis is a primary complaint in 90% to 96% of patients with hereditary hemorrhagic telangiectasia (HHT). …
The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Albarki H, Rimmer J. Albarki H, et al. Am J Rhinol Allergy. 2022 Nov;36(6):890-896. doi: 10.1177/19458924221118131. Epub 2022 Aug 4. Am J Rhinol Allergy. 2022. PMID: 35929049 Review.
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease affecting 1 in 5000 individuals. ...
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease affecting 1 in 5000 individual …
Oral manifestations and dental considerations of patients with hereditary hemorrhagic telangiectasia: a scoping review.
Niklasson J, Rönnblom A, Lidian A, Thor A. Niklasson J, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023 Dec;136(6):691-702. doi: 10.1016/j.oooo.2023.08.001. Epub 2023 Aug 9. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023. PMID: 37752017 Free article. Review.
OBJECTIVE: We examined the range, nature, and extent of research conducted regarding the oral and dental implications of hereditary hemorrhagic telangiectasia (HHT) to identify gaps in the research and knowledge of the field. ...CONCLUSIONS: Oral telangiectas …
OBJECTIVE: We examined the range, nature, and extent of research conducted regarding the oral and dental implications of hereditary …
Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management.
Sautter NB, Smith TL. Sautter NB, et al. Int Forum Allergy Rhinol. 2012 Sep-Oct;2(5):422-31. doi: 10.1002/alr.21046. Epub 2012 May 7. Int Forum Allergy Rhinol. 2012. PMID: 22566463 Review.
BACKGROUND: Epistaxis is the most common manifestation of hereditary hemorrhagic telangiectasia (HHT), affecting approximately 90% of patients at some point during their lifetime. ...METHODS: A systematic review of the literature for HHT-related epistaxis was …
BACKGROUND: Epistaxis is the most common manifestation of hereditary hemorrhagic telangiectasia (HHT), affecting approx …
Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature.
Jackson SB, Villano NP, Benhammou JN, Lewis M, Pisegna JR, Padua D. Jackson SB, et al. Dig Dis Sci. 2017 Oct;62(10):2623-2630. doi: 10.1007/s10620-017-4719-3. Epub 2017 Aug 23. Dig Dis Sci. 2017. PMID: 28836046 Free PMC article. Review.
Hereditary hemorrhagic telangiectasia (HHT), also called Osler-Weber-Rendu syndrome, is an autosomal dominant genetic disease that affects the vasculature of numerous organs. ...
Hereditary hemorrhagic telangiectasia (HHT), also called Osler-Weber-Rendu syndrome, is an autosomal dominant genetic d …
Neurologic Complications in Hereditary Hemorrhagic Telangiectasia with Pulmonary Arteriovenous Malformations: A Systematic Review.
Agarwal J, LaBranche J, Dhillon S, Allison WT, Jeerakathil T, Vethanayagam D. Agarwal J, et al. Can J Neurol Sci. 2023 Jul;50(4):561-572. doi: 10.1017/cjn.2022.80. Epub 2022 Jun 10. Can J Neurol Sci. 2023. PMID: 35686303
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant multi-organ condition occurring with a 1 in 3800 prevalence in Alberta. ...PAVMs were addressed in all these articles in association with various neurological conditions ranging …
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant multi-organ condition occurring with a …
Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature.
Arizmendez NP, Rudmik L, Poetker DM. Arizmendez NP, et al. Int Forum Allergy Rhinol. 2015 Nov;5(11):1042-7. doi: 10.1002/alr.21587. Epub 2015 Jul 22. Int Forum Allergy Rhinol. 2015. PMID: 26202958 Review.
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is a multisystem disease that is marked by mutations regulating vasculature formation. ...
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is a multisystem disease that is marked by mutations regulating …
27 results